- Home
- THCH vs CLNN Comparison
THCH vs CLNN Comparison
Compare THCH & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THCH | CLNN |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | China | United States |
| Employees | 1580 | 79 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 67.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | THCH | CLNN |
|---|---|---|
| Price | $1.63 | $5.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | 6.1K | ★ 53.6K |
| Earning Date | 04-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.24 | $3.50 |
| 52 Week High | $3.25 | $13.50 |
Technical Indicators
Market Signals| Indicator | THCH | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 38.66 |
| Support Level | $1.24 | $4.53 |
| Resistance Level | $1.99 | $6.61 |
| Average True Range (ATR) | 0.22 | 0.38 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 33.33 | 49.45 |
Price Performance
Historical ComparisonAbout THCH TH International Limited Ordinary shares
TH International Ltd is the exclusive master franchisee in China for Tim Hortons, a world-wide coffee and bakery shop brand. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under a single reportable segment, Tim Hortons. The company's revenue is derived from sales of food, beverages, and packaged products by company-owned and operated stores, franchise fees, and revenue from other franchise support activities. Its geographic revenue is derived from operations in the PRC.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.